Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy

European Archives of Psychiatry and Clinical Neuroscience
Astrid ZobelWolfgang Maier

Abstract

Excess comorbidity between depression and epilepsy proposes common pathophysiological patterns in both disorders. Neuroendocrine abnormalities were often observed in depression as well as in epilepsy. Lack of inhibitory control of the hypothalamic pituitary adrenocortical (HPA) system is a core feature of depression; main relay stations of this system are located in the amygdala and hippocampus, which are key regions for both disorders. Therefore we explored the feedback mechanism of the HPA system in epilepsy. In order to control for the impact of depression we focused on epilepsies without depression. We compared patients with epilepsy (subdivided by medication with or without hepatic enzyme inducing antiepileptic medication) with 16 healthy controls and 16 patients with unipolar major depression but without epilepsy. We observed a lack of inhibitory control of the HPA system in patients with epilepsy, also in the absence of enzyme inducing medication. An impact of the temporal lobe location of the epileptic focus could not be observed. Thus, epilepsies share with depression the deficiencies in the feedback mechanism of the HPA system, proposing common pathophysiological features of up to now unknown nature.

Citations

Jun 12, 2009·Current Neurology and Neuroscience Reports·Andres M Kanner
Mar 20, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Eduardo A PinedaAndréy M Mazarati
Feb 25, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eduardo A PinedaAndréy M Mazarati
Jun 19, 2008·Brain : a Journal of Neurology·Andréy MazaratiRaman Sankar
Jan 5, 2007·Epilepsia·Michael SalzbergTerrence J O'Brien
Dec 5, 2008·Epilepsia·Sadat ShamimWilliam H Theodore
Jan 19, 2011·Epilepsia·Andres M Kanner
Jun 29, 2012·Epilepsia·Jolien S van CampenKees P J Braun
Apr 11, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Andres M KannerMatthias Koepp
Jun 16, 2014·Journal of the Neurological Sciences·Alberto VerrottiMario Fulcheri
Oct 23, 2013·Epilepsy & Behavior : E&B·Jolien S van CampenMarian Joels
Jul 27, 2011·Steroids·Martin HillLuboslav Stárka
May 31, 2011·Epilepsy & Behavior : E&B·Hrvoje HecimovicJohn J Barry
Sep 28, 2015·Epilepsy & Behavior : E&B·Germain Jean Magloire Ketcha WandaDieudonné Njamen
Nov 11, 2009·Neurobiology of Disease·Andrey M MazaratiRaman Sankar
Mar 17, 2009·Neurobiology of Disease·Andrey M MazaratiRaman Sankar
Jun 26, 2007·Biological Psychiatry·Gregor HaslerWilliam H Theodore
Jan 12, 2007·Epilepsy & Behavior : E&B·Elizabeth J RichardsonMichael Seidenberg
Nov 14, 2012·British Journal of Pharmacology·L CardamoneN C Jones
Dec 6, 2005·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Julian F ThayerJoachim E Fischer
Jun 7, 2015·Brain : a Journal of Neurology·Jolien S van CampenKees P J Braun
Jun 21, 2011·Experimental Neurology·Steve C Danzer
May 24, 2015·Journal of Affective Disorders·Emmanuelle C S BostockBruce V M Taylor
Dec 4, 2012·Epilepsy & Behavior : E&B·Jamie Maguire, Jay A Salpekar
Jan 13, 2006·Seizure : the Journal of the British Epilepsy Association·M Said BerilgenCaner Demir
May 20, 2016·Physiology & Behavior·Aynara C WulsinJames P Herman
Aug 9, 2016·Physiology & Behavior·Gretchen N Neigh, Jennifer C Felger
Sep 17, 2016·Pharmacological Reports : PR·Barbara Błaszczyk, Stanisław J Czuczwar
Dec 31, 2016·Epilepsia·Teresa RavizzaAlon Friedman
May 12, 2017·Epilepsy & Behavior : E&B·Iliana KotwasJean-Arthur Micoulaud-Franchi
Nov 16, 2010·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Nikki T Sawyer, Andrew Escayg
Sep 25, 2007·Journal of Neurochemistry·Daniel KondziellaUrsula Sonnewald
Dec 29, 2006·Annals of the New York Academy of Sciences·Julian F Thayer, Esther Sternberg
Nov 26, 2015·Der Nervenarzt·M BorgmannJ Behr
Apr 30, 2019·Human Brain Mapping·Adam M GoodmanJerzy P Szaflarski
Jun 9, 2018·Epilepsia Open·Jesús-Servando Medel-MatusAndrey Mazarati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.